94
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Virosomes can enter cells by non-phagocytic mechanisms

, , , , &
Pages 301-309 | Received 08 Jan 2009, Accepted 20 Mar 2009, Published online: 28 Oct 2009

References

  • Albert ML, Sauter B, Bhardwaj N. (1998). Dendritic cells acquire antigen from apoptotic cells and induce class I–restricted CTLs. Nature 392:86–89.
  • Arcangeletti MC, De Conto F, Ferraglia F, Pinardi F, Gatti R, Orlandini G, et al. (2008). Host-cell–dependent role of actin cytoskeleton during the replication of a human strain of influenza A virus. Arch Virol 153:1209–1221.
  • Axline SG, Reaven EP. (1974). Inhibition of phagocytosis and plasma membrane mobility of the cultivated macrophage by cytochalasin B. Role of subplasmalemmal microfilaments. J Cell Biol 62:647–659.
  • Bungener L, Huckriede A, Wilschut J, Daemen T. (2002). Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs. Biosci Rep 22:323–338.
  • Daemen T, de Mare A, Bungener L, de Jonge J, Huckriede A, Wilschut J. (2005). Virosomes for antigen and DNA delivery. Adv Drug Deliv Rev 57:451–463.
  • Felnerova D, Viret JF, Gluck R, Moser C. (2004). Liposomes and virosomes as delivery systems for antigens, nucleic acids, and drugs. Curr Opin Biotechnol 15:518–529.
  • Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, et al. (2005). Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect 113:1555–1560.
  • Gluck R. (2002). Intranasal immunization against influenza. J Aerosol Med 15:221–228.
  • Gluck R, Mischler R, Brantschen S, Just M, Althaus B, Cryz SJ, Jr. (1992). Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A. J Clin Invest 90:2491–2495.
  • Holt PG. (2005). Pulmonary dendritic cells in local immunity to inert and pathogenic antigens in the respiratory tract. Proc Am Thorac Soc 2:116–120.
  • Huckriede A, Bungener L, Stegmann T, Daemen T, Medema J, Palache AM, et al. (2005). The virosome concept for influenza vaccines. Vaccine 23(Suppl 1):S26–S38.
  • Inaba K, Metlay JP, Crowley MT, Steinman RM. (1990). Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 172:631–640.
  • Ivanov AI. (2008). Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Meth Mol Biol 440:15–33.
  • Jeon SH, Kayhan B, Ben-Yedidia T, Arnon R. (2004). A DNA aptamer prevents influenza infection by blocking the receptor-binding region of the viral hemagglutinin. J Biol Chem 279:48410–48419.
  • Kaksonen M, Toret CP, Drubin DG. (2006). Harnessing actin dynamics for clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 7:404–414.
  • Keller H, Niggli V. (1995). Effects of cytochalasin D on shape and fluid pinocytosis in human neutrophils as related to cytoskeletal changes (actin, alpha-actinin, and microtubules). Eur J Cell Biol 66:157–164.
  • Lambkin R, Oxford JS, Bossuyt S, Mann A, Metcalfe IC, Herzog C, et al. (2004). Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine. Vaccine 22(31–32):4390–4396.
  • Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. (1976). A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17:62–70.
  • Matlin KS, Reggio H, Helenius A, Simons K. (1981). Infectious entry pathway of influenza virus in a canine kidney cell line. J Cell Biol 91(3 Pt 1):601–613.
  • Mischler R, Metcalfe IC. (2002). Inflexal V a trivalent virosome subunit influenza vaccine: production. Vaccine 20(Suppl 5):B17–B23.
  • Moser C, Metcalfe IC, Viret JF. (2003). Virosomal adjuvanted antigen delivery systems. Expert Rev Vaccines 2:189–196.
  • Muhlfeld C, Rothen-Rutishauser B, Blank F, Vanhecke D, Ochs M, Gehr P. (2008). Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol Lung Cell Mol Physiol 294:L817–L829.
  • Nicod LP. (1997). Function of human lung dendritic cells. In: Lipscomb MF, Russels SW (Eds.), Health and Disease (pp 311–334 ), New York/Basel: Marcel Dekker, Inc.
  • Raghu H, Sharma-Walia N, Veettil MV, Sadagopan S, Chandran B. (2009). Kaposi’s sarcoma associated herpesvirus (KSHV) utilizes actin polymerization dependent macropinocytic pathway to enter human dermal microvascular endothelial (HMVEC-d) and human umbilical vein endothelial (HUVEC) cells. J Virol. 83(10): 4895–911.
  • Rothen-Rutishauser B, Muhlfeld C, Blank F, Musso C, Gehr P. (2007). Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part Fibre Toxicol 4:9.
  • Rothen-Rutishauser BM, Kiama SG, Gehr P. (2005). A three- dimensional cellular model of the human respiratory tract to study the interaction with particles. Am J Respir Cell Mol Biol 32:281–289.
  • Rothen-Rutishauser BM, Schurch S, Haenni B, Kapp N, Gehr P. (2006). Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 40:4353–4359.
  • Sallusto F, Cella M, Danieli C, Lanzavecchia A. (1995). Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182:389–400.
  • Sun X, Whittaker GR. (2007). Role of the actin cytoskeleton during influenza virus internalization into polarized epithelial cells. Cell Microbiol 9:1672–1682.
  • Thiele L, Rothen-Rutishauser B, Jilek S, Wunderli-Allenspach H, Merkle HP, Walter E. (2001). Evaluation of particle uptake in human blood monocyte–derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J Contr Rel 76(1–2):59–71.
  • Thompson HM, McNiven MA. (2006). Discovery of a new “dynasore.” Nat Chem Biol 2:355–356.
  • Waelti E, Wegmann N, Schwaninger R, Wetterwald A, Wingenfeld C, Rothen-Rutishauser B, et al. (2002). Targeting her-2/neu with antirat Neu virosomes for cancer therapy. Cancer Res 62:437–444.
  • Waelti ER, Gluck R. (1998). Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid- reconstituted influenza-virus envelopes (cationic virosomes). Int J Cancer 77:728–733.
  • Zurbriggen R, Novak-Hofer I, Seelig A, Gluck R. (2000). IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization. Prog Lipid Res 39:3–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.